Analyzing Biocorrx (OTCMKTS:BICX) & Bioqual (OTCMKTS:BIOQ)

Bioqual (OTCMKTS:BIOQ) and Biocorrx (OTCMKTS:BICX) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership and dividends.

Profitability

This table compares Bioqual and Biocorrx’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Bioqual	-2.27%	-2.69%	-1.50%
Biocorrx	N/A	N/A	-90.89%

Analyst Recommendations

This is a breakdown of current ratings and price targets for Bioqual and Biocorrx, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bioqual	0	0	0	0	0.00
Biocorrx	0	1	0	0	2.00

Volatility and Risk

Bioqual has a beta of -0.2, meaning that its share price is 120% less volatile than the S&P 500. Comparatively, Biocorrx has a beta of 0.19, meaning that its share price is 81% less volatile than the S&P 500.

Valuation and Earnings

This table compares Bioqual and Biocorrx”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bioqual	$48.87 million	0.60	-$1.05 million	($1.08)	-30.56
Biocorrx	$800,000.00	7.81	-$3.44 million	($0.12)	-1.75

Bioqual has higher revenue and earnings than Biocorrx. Bioqual is trading at a lower price-to-earnings ratio than Biocorrx, indicating that it is currently the more affordable of the two stocks.

Summary

Biocorrx beats Bioqual on 7 of the 10 factors compared between the two stocks.

About Bioqual

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is based in Rockville, Maryland.

About Biocorrx

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.